CVR number 28512457K
Industry 72.1100 Research and experimental development on biotechnology

GLYCOM A/S - Group

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Bankruptcy risk for industry  1.2% 1.2% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 1.8% 5.8% 29.0%  
Credit score (0-100)  0 0 73 42 2  
Credit rating  N/A N/A A BBB B  
Credit limit (kDKK)  0.0 0.0 11.3 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 43,125 0  
Gross profit  0.0 0.0 10,786 -3,322 0.0  
EBITDA  0.0 0.0 -2,377 -37,206 0.0  
EBIT  0.0 0.0 -7,178 -55,250 0.0  
Pre-tax profit (PTP)  0.0 0.0 -22,690.0 -75,199.0 0.0  
Net earnings  0.0 0.0 -18,114.0 -63,124.0 0.0  
Pre-tax profit without non-rec. items  0.0 0.0 -28,804 -75,199 0.0  
 
See the entire income statement

Balance sheet (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Tangible assets total  0.0 0.0 4,345 700,386 0.0  
Shareholders equity total  0.0 0.0 21,887 13,775 0.0  
Interest-bearing liabilities  0.0 0.0 354,611 842,227 0.0  
Balance sheet total (assets)  0.0 0.0 401,553 1,023,715 0.0  
Net Debt  0.0 0.0 341,404 815,214 0.0  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 43,125 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% -100.0%  
Gross profit  0.0 0.0 10,786 -3,322 0.0  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 43 117 0  
Employee growth %  0.0% 0.0% 0.0% 172.1% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 401,553 1,023,715 0  
Balance sheet change%  0.0% 0.0% 0.0% 154.9% -100.0%  
Added value  0.0 0.0 -2,377.0 -50,449.0 0.0  
Added value %  0.0% 0.0% 0.0% -117.0% 0.0%  
Investments  0 0 179,754 741,933 -944,532  
Net sales trend  0.0 0.0 0.0 0.0 -1.0  
EBIT trend  0.0 0.0 -1.0 -2.0 0.0  

Profitability 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
EBITDA %  0.0% 0.0% 0.0% -86.3% 0.0%  
EBIT %  0.0% 0.0% 0.0% -128.1% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -66.5% 1,663.2% 0.0%  
Net Earnings %  0.0% 0.0% 0.0% -146.4% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% -104.5% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% -174.4% 0.0%  
ROA %  0.0% 0.0% -1.7% -7.8% 0.0%  
ROI %  0.0% 0.0% -1.8% -9.0% 0.0%  
ROE %  0.0% 0.0% -82.8% -354.0% 0.0%  

Solidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Equity ratio %  0.0% 0.0% 5.5% 1.5% 0.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 2,281.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 2,218.4% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -14,362.8% -2,191.1% 0.0%  
Gearing %  0.0% 0.0% 1,620.2% 6,114.2% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 12.5% 3.3% 0.0%  

Liquidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Quick Ratio  0.0 0.0 0.4 0.2 0.0  
Current Ratio  0.0 0.0 0.4 0.1 0.0  
Cash and cash equivalent  0.0 0.0 13,207.0 27,013.0 0.0  

Capital use efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 487.7 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 122.3% 0.0%  
Net working capital  0.0 0.0 -11,827.0 -304,295.0 0.0  
Net working capital %  0.0% 0.0% 0.0% -705.6% 0.0%  

Employee efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales / employee  0 0 0 369 0  
Added value / employee  0 0 -55 -431 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -55 -318 0  
EBIT / employee  0 0 -167 -472 0  
Net earnings / employee  0 0 -421 -540 0